Mutations in a NIMA-related kinase gene, Nek1 , cause pleiotropic effects including a progressive polycystic kidney disease in mice

Poornima Upadhya, E H Birkenmeier, Connie S. Birkenmeier, Jane E. BarkerProceedings of the National Academy of Sciences 2000 · DOI

TL;DR

Researchers have identified mutations in the Nek1 gene as the cause of a progressive polycystic kidney disease (PKD) in mice, along with a suite of other developmental defects. This discovery reveals a previously unknown role for Nek1 in kidney development and opens new avenues for understanding and potentially treating human PKD.

What Problem Does This Paper Address?

Polycystic kidney disease (PKD) is a common inherited disorder characterized by the growth of fluid-filled cysts in the kidneys, leading to massive renal enlargement and eventual kidney failure. While the primary genetic causes of human autosomal-dominant PKD (ADPKD) have been identified (PKD1 and PKD2), the mechanisms underlying cyst formation and the factors that influence disease severity remain incompletely understood. Animal models are crucial for dissecting these complex processes. This paper addresses the need to identify the specific gene responsible for a particular mouse model of PKD, characterized by a slow-onset, progressive disease and a range of other pleiotropic effects (facial dysmorphism, dwarfing, male sterility, anemia, and cystic choroid plexus). Understanding the molecular basis of this model can shed light on the broader pathways involved in kidney development and cystogenesis.

Methods

The researchers employed a multi-pronged approach combining genetic mapping, positional cloning, and molecular analysis:

  • Genetic and Physical Mapping: They fine-mapped the kat<sup>2J</sup> mutation to a specific region on mouse chromosome 8 using genetic markers. To pinpoint the gene, they constructed an integrated genetic and physical map of this critical region.
  • Positional Cloning: They screened yeast artificial chromosome (YAC), bacterial artificial chromosome (BAC), and P1 libraries to identify clones that spanned the mapped region.
  • Candidate Gene Identification: They performed expression analysis of transcribed sequences within the mapped region. This led to the identification of Nek1 (a NIMA-related kinase) as a strong candidate gene.
  • Molecular Characterization of Mutations: They analyzed the Nek1 gene in mutant mice. This involved PCR amplification and sequencing of the gene from both kat/kat and kat<sup>2J</sup>/kat<sup>2J</sup> animals.
  • Expression Analysis: Northern blotting was used to examine Nek1 mRNA levels in mutant and wild-type mice.
  • Mutation Confirmation: Southern blotting and RT-PCR were used to confirm the nature of the mutations (deletion and insertion) and their impact on the Nek1 gene and its transcript.

Datasets

Not discussed in the paper. The study primarily relies on analyzing DNA and RNA from mouse models and publicly available genomic databases for sequence comparisons.

Key Insights and Ideas

  • Nek1's Unexpected Role in Kidney Development: The study reveals that Nek1, a kinase previously known for its role in cell division, is also critical for normal kidney development and function. This is a novel finding that expands our understanding of this kinase family.
  • Pleiotropic Effects Suggest a Multifunctional Protein: The diverse range of phenotypes observed in the mutant mice (PKD, facial dysmorphism, sterility, anemia) strongly suggests that NEK1 is a multifunctional protein involved in multiple signaling pathways that regulate various cellular processes beyond just cell division.
  • Nek1 as a Potential Modifier of PKD Severity: The variability in PKD severity observed in different genetic backgrounds hints that Nek1 might interact with other genetic factors to influence disease progression, offering a new angle for understanding ADPKD.
  • Two Distinct Mutations Lead to Similar Phenotypes: The identification of a large internal deletion in kat/kat and a single-base insertion in kat<sup>2J</sup>/kat<sup>2J</sup> that both result in a loss of functional NEK1 protein suggests that these mutations likely lead to a null phenotype, underscoring the critical importance of Nek1 function.

Key Results

  • Identification of Nek1 as the causative gene: Through positional cloning and expression analysis, the Nek1 gene was identified as the gene affected by the kat and kat<sup>2J</sup> mutations.
  • Molecular basis of mutations:
    • The kat/kat mutation results in a large internal deletion within the Nek1 gene, affecting most of the kinase domain.
  • The kat<sup>2J</sup>/kat<sup>2J</sup> mutation is caused by a single-base guanosine insertion, leading to a frameshift and a premature stop codon, truncating the NEK1 protein.
  • Altered Nek1 expression: Northern blot analysis showed reduced levels of Nek1 transcripts in the kidneys and testes of mutant mice, consistent with the identified mutations.
  • Mouse model recapitulates human PKD: The progressive polycystic kidney disease observed in homozygous mutants shares pathological similarities with human autosomal-dominant PKD.

Limitations and Future Work

  • Limitations:
    • The exact functional domains affected by the kat deletion and the precise consequences of the kat<sup>2J</sup> truncation on protein activity are not fully detailed.
  • While Nek1 is implicated, the specific signaling pathways it participates in within the kidney and other affected tissues are still largely unknown.
  • Future Work:
    • The authors propose that identifying proteins that interact with NEK1 will be crucial for substantiating their speculation about its role in signaling pathways related to PKD and AP-1 transcription factor activation.
  • They are generating congenic strains to further investigate modifier loci that influence PKD severity, which could reveal other interacting factors.
  • Further research into the specific roles of NEK1 in cellular proliferation, differentiation, and transport functions within renal epithelial cells is warranted.
  • The study opens avenues for exploring therapeutic interventions for human PKD by targeting the pathways involving NEK1.

Summary updated

Abstract

We previously have described a mouse model for polycystic kidney disease (PKD) caused by either of two mutations, kat or kat(2J), that map to the same locus on chromosome 8. The homozygous mutant animals have a latent onset, slowly progressing form of PKD with renal pathology similar to the human autosomal-dominant PKD. In addition, the mutant animals show pleiotropic effects that include facial dysmorphism, dwarfing, male sterility, anemia, and cystic choroid plexus. We previously fine-mapped the kat(2J) mutation to a genetic distance of 0.28 +/- 0.12 centimorgan between D8Mit128 and D8Mit129. To identify the underlying molecular defect in this locus, we constructed an integrated genetic and physical map of the critical region surrounding the kat(2J) mutation. Cloning and expression analysis of the transcribed sequences from this region identified Nek1, a NIMA (never in mitosis A)-related kinase as a candidate gene. Further analysis of the Nek1 gene from both kat/kat and kat(2J)/kat(2J) mutant animals identified a partial internal deletion and a single-base insertion as the molecular basis for these mutations. The complex pleiotropic phenotypes seen in the homozygous mutant animals suggest that the NEK1 protein participates in different signaling pathways to regulate diverse cellular processes. Our findings identify a previously unsuspected role for Nek1 in the kidney and open a new avenue for studying cystogenesis and identifying possible modes of therapy.
BibTeX
@inproceedings{upadhya2000mutations,
  author = {Poornima Upadhya and E H Birkenmeier and Connie S. Birkenmeier and Jane E. Barker},
  title = {{Mutations in a NIMA-related kinase gene, <i>Nek1</i> , cause pleiotropic effects including a progressive polycystic kidney disease in mice}},
  booktitle = {Proceedings of the National Academy of Sciences},
  year = {2000},
  doi = {10.1073/pnas.97.1.217},
}
Figure